Health Care: Drugs

Johnson & Johnson (JNJ: NYSE)

$122.825 1.065 | 0.87%
04/24/17 - 01:21 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 71.89B 70.07B 74.33B 71.31B
Cost of Sales 17.93B 17.79B 18.85B 18.24B
Gross Operating Profit 53.96B 52.28B 55.48B 53.07B
Selling, General, and Administrative Expenses 19.95B 21.20B 21.95B 21.83B
Research & Development 9.10B 9.05B 8.49B 8.18B
Operating Income before D & A (EBITDA) 24.92B 22.04B 25.03B 23.06B
Depreciation & Amortization 3.75B 3.75B 3.90B 4.10B
Interest Income 368.00M 128.00M 67.00M 74.00M
Other Income - Net -1.00B 1.33B -108.00M -2.50B
Special Income / Charges 0.00 0.00 0.00 -1.16B
Total Income Before Interest Expenses (EBIT) 20.53B 19.75B 21.10B 15.95B
Interest Expense 726.00M 552.00M 533.00M 482.00M
Pre-Tax Income 19.80B 19.20B 20.56B 15.47B
Income Taxes 3.26B 3.79B 4.24B 1.64B
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 16.54B 15.41B 16.32B 13.83B
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 16.54B 15.41B 16.32B 13.83B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 16.54B 15.41B 16.32B 13.83B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
16.54B 15.41B 16.32B 14.41B
Preferred Dividends
Net Income Available To Common 16.54B 15.41B 16.32B 13.83B
Basic EPS from Continuing Ops. 6.04 5.56 5.80 4.92
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 6.04 5.56 5.80 4.92
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 6.04 5.56 5.80 4.92
Basic Normalized Net Income/Share 6.04 5.56 5.80 5.13
EPS fr Continuing Ops. 5.93 5.48 5.70 4.81
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 5.93 5.48 5.70 4.81
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 5.93 5.48 5.70 4.81
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
5.93 5.48 5.70 5.01
Dividends Paid per Share 3.15 2.95 2.76 2.59

Portfolios with JNJ

Latest JNJ Headlines from TheStreet

More Financial News for JNJ

Press Releases for JNJ

See All Press Releases
brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter